TUFTS LINDA
Insider CIK 1388680 · PHAS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-02-27 | 2019-03-01 | 36,000 | — | $0 | 36,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 18 | $5.00 | $90 | 34,968 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 710 | $0.12 | $85 | 34,986 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 3,359 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 3,359 | $0.12 | $403 | 165,476 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 81 | $5.00 | $405 | 165,395 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 9,847 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 9,847 | $0.12 | $1.2K | 47,377 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 237 | $5.00 | $1.2K | 47,140 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 991 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 991 | $0.12 | $119 | 4,770 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 24 | $5.00 | $120 | 4,746 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 4,690 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 4,690 | $0.12 | $563 | 22,565 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 113 | $5.00 | $565 | 22,452 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 119,408 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 7,053 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 12,025 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 56,874 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 347,250 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 34,968 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 710 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 170 | $5.00 | $850 | 347,250 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 7,053 | $0.12 | $846 | 347,420 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 30,334 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 6,413 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 63,688 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 22,452 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 4,746 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 47,140 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 165,395 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 577,486 | — | $0 | 577,486 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 6,041 | $5.00 | $30.2K | 281,096 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 275,055 | — | $0 | 275,055 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 1,277 | $5.00 | $6.4K | 59,429 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 58,152 | — | $0 | 58,152 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 12,682 | $5.00 | $63.4K | 590,168 | SEC↗ |